Iron, heme oxygenase, and glutathione: Effects on myohemoglobinuric proximal tubular injury  by Zager, Richard A. et al.
Kidney International, Vol. 48 (1995), pp. 1624—1634
Iron, heme oxygenase, and glutathione: Effects on
myohemoglobinuric proximal tubular injury
RICHARD A. ZAGER, KIRSTIN M. BURKHART, DUANE Scovr CONRAD, and DENNIS J. GMUR
Fred Hutchinson Cancer Research Center, and the Department of Medicine, the University of Washington, Seattle, Washington, USA
Iron, heme oxygenase, and glutathione: Effects on myohemoglobinuric
proximal tubular injury. This study assessed the impacts of iron, heme
oxygenase (HO), hydroxyl radical ('OH), and glutathione (GSH) on the
initiation phase of myohemoglobinuric proximal tubular injury using a
novel model system. Rhabdomyolysis was induced in rats by glycerol
injection and four hours later proximal tubular segments (PTS) were
isolated. They were incubated for 0 to 90 minutes either in the presence or
absence of an iron chelator (deferoxamine; DFO), 'OH scavengers, an
•OH trapping agent (salicylate; to gauge •OH production), GSH, or
catalase. In selected experiments, an HO inhibitor (Sn protoporphyrin)
was given at the time of glycerol injection to assess HO's acute effects on
the evolving injury. Cell death and lipid peroxidation were quantified by %
LDH release and malondialdehyde (MDA) generation, respectively. PTS
from normal rats served as controls. Post-glycerol PTS manifested pro-
gressive LDH release (47 2%) and 20-fold MDA increments during the
incubations, whereas only 11 1% LDH release and no MDA generation
was observed in the normal PTS. DFO completely prevented both
parameters of glycerol-induced injury. HO inhibition exerted an acute
protective effect, despite previous in vivo data suggesting that HO is a
cytoprotectant. Neither 'OH scavengers nor catalase mitigated post-
glycerol injury, the latter correlating with reduced, not increased, 'OH
production. GSH slightly decreased LDH release while causing a para-
doxical threefold MDA increment. The latter was iron dependent
(blocked by DFO), was expressed in normal PTS, and it could be
reproduced by equimolar cysteine. That GSH increased iron-dependent
lipid peroxidation in a cell free system (exogenous phosphatidylcholine)
indicated that GSH metabolism to cysteine was not a requirement for this
reaction. In conclusion: (1) chelatable iron can fully account for heme
protein-triggered proximal tubular injury; (2) HO contributes to this
injury, presumably by causing iron release; (3) the heme-induced injury
appears to be mediated by non-.OH oxidizing intermediates; (4) GSH can
exert both anti- and pro-oxidant effects; and (5) i.m. glycerol injection,
followed by proximal tubular isolation, represents a new and highly useful
model for studying direct determinants of heme protein cytotoxicity.
The pathogenesis of rhabdomyolysis-induced acute renal fail-
ure (ARF) has long been a subject of interest, particularly since its
occurrence in "epidemic" proportions during the London bomb-
ing raids of World War II. Since that time, it has become clear that
this form of renal injury has a multifactorial basis [1]: heme
proteinuria leads to cast formation and early tubular obstruction
[2—4]; proximal tubular cell heme protein endocytosis results,
leading to heme protein cytotoxicity [4—6]; intravascular volume
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depletion and direct heme effects (such as nitric oxide scavenging
[7, 8]) produce renal vasoconstriction and potential ischemic
tubular injury [9, 10]; and muscle necrosis activates the endotoxin/
TNF cascade, amplifying the evolving renal damage [11, 12]. The
net result of these combined insults is proximal tubular cell
necrosis, the histologic hallmark of this form of ARF.
Despite the above insights, the specific mediator(s) of proximal
tubular necrosis during myohemoglobinuric ARF have been
difficult to define. In large part, this is due to the multifactorial
nature of the insult, which has necessitated whole animal exper-
iments to test specific hypotheses. Nevertheless, this approach has
produced the view that heme iron-driven hydroxyl radical (.OH)
generation is a critical mediator of the evolving tubular damage.
This conclusion is supported by the following pieces of informa-
tion: (1) iron chelation (deferoxamine; DFO) therapy partially
mitigates the extent of tubular necrosis and filtration failure
[13—15]; (2) •OH scavengers [14, 15] and glutathione [16], can
exert protective effects; (3) lipid peroxidation, a biochemical
hallmark of oxidative stress, has been reported in the aftermath of
heme protein nephrotoxicity [13, 14]; and (4) induction or sup-
pression of heme oxygenase (HO; the enzyme which degrades
heme porphyrin), has been shown to decrease or increase the
severity of myohemoglobinuric (glycerol) ARF, respectively [17].
This strongly suggests that porphyrin iron is pathogenetically
involved.
Although the above evidence strongly supports a role for heme
iron as a mediator of myohemoglobinuric ARF, several important
questions need to be addressed. First, given the multifactorial
nature of myohemoglobinuric ARF, is it possible that the protec-
tive effects of iron chelation and antioxidant therapy are mediated
via improvements in hemodynamics or decrements in cast forma-
tion, rather than by protecting directly at the proximal tubular cell
level? That DFO and antioxidants can increase solute excretion,
potentially decreasing cast formation, raise this possibility [15, 19].
Second, lipid peroxidation has not been consistently documented
in the aftermath of myohemoglobinuric ARF [19, 20]; thus, the
question of iron-induced oxidant tubular damage has remained in
doubt. Third, if heme-liberated iron is a mediator of proximal
tubular necrosis (as suggested by the fact that iron chelation
confers partial in vivo protection [13—15]), one would expect that
acute HO inhibition (which should prevent heme iron liberation
[21]) would exert a cytoprotective, rather than an injury-potenti-
ating, effect [17, 18]. Fourth, although DFO, 'OH scavengers, and
glutathione may each exert protective influences, their beneficial
in vivo effects have been incomplete, at best [13—16]. Thus, it
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remains possible that these agents are either not directed at some
of the critical mediators of the evolving damage, or that they may
exert some partially offsetting injurious effects. That DFO can
increase iron driven 'OH generation and protein oxidation [15],
and that GSH may exacerbate post-ischemic renal injury [22]
support this possibility.
In an attempt to resolve these issues, we have recently devel-
oped a new strategy for studying myohemoglobinuric proximal
tubular injury. Rhabdomyolysis/hemolysis were induced in vivo by
intramuscular glycerol injection, and four hours later, a time of
evolving tubular damage, proximal tubular segments (PTS) were
isolated to permit direct assessments of the involved injury
pathways. This approach was used to address the issues raised
above. The results obtained form the basis of this report.
Methods
Animal experimentation: Proximal tubular segment preparation
Glycerol-induced myohemoglobinuria. Male Sprague-Dawley
rats (125 to 250 g; Charles River Laboratories, Wilmington, MA,
USA), maintained under standard vivarium conditions, were used
for all experiments. They were lightly anesthetized with pentobar-
bital (---30 mg/kg) and then immediately injected with 8 ml/kg of
50% glycerol, administered in equally divided doses into the hind
limbs. They were placed under heating lamps, a rectal tempera-
ture probe was inserted, and body temperature was maintained at
36 to 37°C until recovery from anesthesia (that is, restitution of
ability to thermoregulate). [Note: pilot data indicated that a
failure to maintain a normal body temperature prevented subse-
quent tubular injury. Four hours after glycerol injection, the rats
were re-anesthetized with pentobarbital, the kidneys were re-
moved and used for PTS preparation. Normal rats, treated in an
identical fashion except for no glycerol injection, provided control
PTS.
PTS preparation, experimentation procedures, and assessments of
injury. Following kidney resection, PTS were isolated as previously
described [23]. In brief, the kidneys were cooled to 4°C, and the
cortices were dissected and finely minced with a razor blade. This
was followed by 30 minutes of collagenase digestion (type D;
Boehringer-Mannheim, Indianapolis, IN, USA; 1.5 mg/ml) in a
buffer containing (in mmol/liter): NaC1, 100; KC1, 2.1; NaHCO3,
25; KH2PO4, 2.4; MgSO4, 1.2; MgCl2, 1.2; CaCl2, 1.2; glucose, 5;
alanine, 1; Na lactate, 4; dextran, 0.6%; gassed with 95% 02/5%
CO2 (02/C02). [Note: the starting pH of this buffer was 7.4;
however, for the sake of collagenase digestion, the pH was
lowered to 6.5 by 0.5 N HCI addition to improve tubule yield and
subsequent viability.] After collagenase digestion (at 36°C), iced
buffer was added to stop the reaction, the tissues were passed
through a stainless steel sieve, and pelleted by centrifugation. The
recovered material was washed with iced buffer, it was layered on
31% Percoll (Pharmacia; Piscataway, NJ, USA), and viable,
pelleted PTS were recovered after centrifugation (3000 rpm, 4°C).
The PTS were washed twice to remove the Percoll and then
suspended (-—3 to 6 mg protein/ml) in a buffer identical to that
above, except for a pH of 7.4 plus the addition of 10 mmol/Iiter Na
butyrate. The PTS were gassed with 02/C02, each preparation
was divided into three to five equal aliquots (depending on the
protocol), and each aliquot (1.25 ml) was added to a 10 ml
Erlenmeyer flask. The flasks were incubated in a 36 to 37°C
shaking water bath for 0 to 90 minutes, depending on the protocol.
% LDH release was assessed at the start of the incubations and at
selected times thereafter [24, 25]. [Note: no PTS re-warm period
was undertaken prior to starting the experiments (such as 15 mm,
as usually performed in this laboratory) because preliminary data
indicated that this was a time of evolving cell injury in the
post-glycerol PTS; see Results.] Comparable tubule yields from
the post-glycerol and from the normal kidneys was confirmed by
the fact that total LDH in these preparations (that is, the amount
of LDH following lysis; a direct reflection of total cell number)
were always highly comparable. Similarly, addition of experimen-
tal agents during collagenase digestion (DFO, Sn protoporphyrin,
see below) also had absolutely no impact on total tubule recovery,
as assessed by total LDH recovery.
The extent of lipid peroxidation was assessed by determining
PTS malondialdehyde (MDA) concentrations at the start of the
incubations and either 30, 75, or 90 minutes thereafter (depending
on the particular protocol). To this end, 5 mivi deferoxamine
(DFO) and 5 mt EDTA were added to the PTS aliquots at the
end of the incubations to stop iron-dependent lipid peroxidation
and to permit overnight storage (—20°C; [241). The samples were
assayed for MDA by the thiobarbituric acid method of Uchiyama
and Mihara [25], as previously performed in this laboratory [19,
20, 24]. Values were expressed as nmol/mg PTS protein, the latter
based on the bicinchoninic acid assay method (Pierce Chemical
Co., Rockford, IL, USA).
Time course of post-glycerol lipid peroxidation and cell death
The following experiment ascertained whether active proximal
tubular injury could be documented in the PTS harvested four
hours post-glycerol injection, and if so, to determine the rate of its
in vitro expression. To these ends, 16 PTS preparations were
obtained from rats either four hours post-glycerol injection (N =
8) or sham injection (N = 8). A baseline sample was saved for
LDH release and MDA assay. The PTS preparations were then
divided into two to four aliquots, they were re-gassed with
02/C02, and incubated for either 0, 15, 75, or 90 minutes (at least
4 separate determinations at each point). On any given day, one
normal rat and one glycerol-treated rat were studied simulta-
neously. At the completion of the incubations, % LDH release
and MDA levels were determined on each aliquot, the results for
the post-glycerol and normal PTS being compared.
Effects of iron chelation on the evolution of post glycerol-induced
tubular injury
The following experiment tested whether, and to what extent,
iron chelation therapy with DFO can block the expression of
glycerol-induced PTS injury. Four rats were injected with glycerol
and four hours later the kidneys were resected. The left kidneys
were subjected to the standard isolation procedure; in contrast,
the right kidneys underwent collagenase digestion in the presence
of 2 mrvi DFO (the DFO was removed during the subsequent
washing procedure). In all other respects the left and right kidneys
were handled in an identical fashion. Each PTS preparation was
divided into two equal aliquots, they were re-gassed with 02/C02,
and incubated for 90 minutes either in the presence or absence of
4 mM DFO. At the completion of the incubations, % LDH release
and MDA concentrations were determined. Thus, in sum, these
experiments created four sets of PTS from post-glycerol injected
rats: (1) no DFO exposure; (2) DFO exposure, but only during
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collagenase digestion; (3) DFO exposure, but only during the 90
minutes experimental incubation period; and (4) DFO exposure
both during collagenase digestion and during the experimental
incubations (N = 4 per each group).
Assessment of PTS hydroxyl radical production
Since it has been suggested that myohemoglobinuric tubular
injury is mediated by iron dependent hydroxyl radical ('OH)
generation via the Fenton/Haber Weiss reactions (such as [13,
14]), •OH production by normal and post-glycerol PTS was
assessed via the salicylate trap method [26, 271, as previously
employed in this laboratory [15]. In brief, salicylate functions as a
stable .OH trap with 2,3- and 2,5-dihydroxybenzoic acid (DHBA)
generation being the result. Thus, total 2,3- and 2,5-DHBA
production serves as an index of the 'OH burden. Fours pairs of
normal and post-glycerol PTS were prepared, 2 mM Na salicylate
was added to each, and then each preparation was divided into
three equal aliquots and subjected to the following incubations:
(1) a 15 minute incubation under normal conditions; (2) a 30
minute incubation under normal conditions; and (3) a 30 minute
incubation in the presence of 4 msi DFO. [Note: the reason for
employing short incubations (15 or 30 mm vs. the usual 90 mm)
was to evaluate DHBA production prior to the onset of substan-
tial differences in the extent of cell death for the two groups, which
would complicate data interpretation. The impact of DFO on
DHBA generation was studied to ascertain whether its cytopro-
tective effect (see Results) correlated with decreased 'OH gener-
ation.1 After completing the incubations, PTS suspensions were
extracted and DHBA concentrations determined by HPLC/elec-
trochemical detection [15]. In addition, % LDH release was
determined on each of the aliquots. DHBA levels in normal PTS
buffer (no PTS) to which 2 ifiM Na salicylate had been added,
established baseline concentrations.
Impact of heme oxygenase inhibition on myohemoglobinuric
PTS injury
Previous data from Nath et a! [17] and this laboratory [18] have
indicated that Sn protoporphyrin treatment (that is, HO inhibi-
tion) at the time of glycerol injection worsens the severity of ARF,
asssessed 24 hours later. However, that HO inhibition retards
porphyrin breakdown, and hence iron release, suggests that these
results are paradoxical (if porphyrin-liberated iron is a critical
mediator of heme-induced tubular damage). The following exper-
iments were undertaken to provide additional insights into this
issue. Twelve PTS preparations were isolated from rats four hours
after i.m. glycerol injection. Half of the rats received a subcuta-
neous injection of Sn protoporphyrin (15 mg/kg in 0.5 ml of
saline) at the time of the glycerol injection; the remaining rats
received only the vehicle. During the collagenase digestion pro-
cess, Sn protoporphyrin (100 g/ml) was added to the samples
obtained from rats which had received in vivo Sn protoporphyrin
treatment (to maintain HO inhibition). The Sn protoporphyrin
subsequently was removed by the post-collagenase washing pro-
cess. Each PTS preparation was divided into four aliquots and
subjected to either 0, 30, 60, or 90 minutes incubations, followed
by assessments of LDH release and MDA generation. [Notes: Sn
protoporphyrin was not added during these incubations to main-
tain HO inhibition since it interfered with subsequent LDH and
MDA assays. Conversely, pilot data confirmed that Sn protopor-
phyrin addition during collagenase digestion does not affect LDH
release, MDA levels, or tubule yields from normal kidneys,
thereby excluding non-specific Sn protoporphyrin effects on these
parameters following its removal.]
The following experiment tested whether Sn protoporphyrin
impacts on glycerol-induced PTS injury even in the absence of its
systemic administration (that is, excluding a possible effect on PTS
injury via a prior vascular or intraluminal effect). To this end, six
rats were injected with glycerol and four hours later the kidneys
were removed. One kidney from each rat was used to prepare PTS
with Sn protoporphyrin added to the collagenase buffer, as noted
above; the contralateral kidney tissue underwent collagenase
digestion in the absence of HO inhibition. The remainder of the
procedures were identical. Then, these PTS preparations were
subjected to the experimental protocol described immediately
above.
Impact of 'OH scavenger therapy on myohemoglobinuric
PTS injury
The following experiments were undertaken to ascertain
whether the in vitro evolution of post-glycerol PTS injury could be
abrogated by 'OH scavenger therapy (benzoate, dimethylthio-
urea, DMTU) [14, 15]. Eight rats were injected with glycerol and
four hours later PTS were isolated. Four of the preparations were
divided into three equal aliquots and subjected to 75 minute
incubations under the following conditions: (1) control incubation
(125 sl of buffer added to equal the volume of the following
additions); (2) Na benzoate (final concentration, 10 mM); or (3)
DMTU (final concentration, 10 mM). The test compounds were
added at the start of the incubations. Finally, % LDH release and
MDA concentrations were determined. (Note: previous data
indicate that these additions do not alter these parameters in
normal PTS, thereby excluding non-specific effects, [15]).
The remaining four PTS preparations were divided into five
equal aliquots and subjected to 90 minutes incubations, as follows:
(1) control incubation; (2) 10 m Na benzoate addition; (3) 10
mM DMTU addition; (4) 4 mi DFO addition; or (5) DFO +
DMTU addition. The reason for aliquots #4 and #5 was to
ascertain whether the addition of a 'OH scavenger would improve
DFO's cytoprotective effect (since DFO can under selected
circumstances cause a paradoxical increase in 'OH production
and oxidant stress [15]).
Assessment of GSH and catalase effects on post-glycerol
PTS injury
Since glycerol injection can increase renal H2O2 production in
vivo [281, and because in vivo GSH therapy can attenuate the
severity of the resulting ARF [161, the impacts of catalase and
GSH on post-glycerol PTS injury were assessed. Seven rats were
injected with glycerol, PTS were isolated four hours later, each
preparation was divided into four aliquots and subjected to the
following incubations: (1) control conditions (only buffer addi-
tion); (2) catalase addition (5000 U/ml; C-40; Sigma Chemicals,
St. Louis, MO, USA); (3) GSH (4 mM; ultra pure grade; G-6529;
Sigma); or (4) glycine (4 mM). Glycine's impact was assessed since
OSH-mediated protection can stem from either its antioxidant
effect or by serving as a source of glycine, a potent cytoprotectant
Zager et al: Myohemoglobinuric injuly 1627
Fig. 1. A. Percent LDH release from normal (II]
control) tubules and from tubules harvested four
hours post-glycerol injection () during 90
minutes incubations. At each time point beyond
time zero, far greater injury was observed in the
post-glycerol group. B. At baseline (zero mm),
the post-glycerol PTS manifested higher MDA
values than the normal PTS, and only the post
glycerol tubules manifested progressive MDA
increments over the course of the incubations.
[29]. After 90 minute incubations, % LDH
levels were determined.
release and MDA
Assessment of GSH's impact on PTS lipid peroxidation
In the above experiment, GSH induced a striking and paradox-
ical increase in lipid peroxidation (Results). The following exper-
iment was undertaken to explore this phenomenon. Four PTS
preparations were obtained four hours following glycerol injection
and each was divided into five equal aliquots: (1) control incuba-
tion; (2) 4 mM GSH addition; (3) 4 mvi GSH + 4 mM DFO
addition; (4) 4 mM cysteine addition; and (5) 4 mM /3-mercapto-
ethanol addition. The rationale for aliquot #3 was to ascertain
whether iron chelation would prevent the GSH-induced MDA
increment (that is, is it iron dependent?). Aliquot #4 was pre-
pared to determine whether cysteine (one of GSH's three constit-
uent amino acids) was the likely mediator of GSH's "pro-oxidant"
effect. Aliquot #5 was established to determine whether GSH's
pro-oxidant effect was due to its sulfhydryl content. After 90
minute incubations, % LDH release and MDA generation were
determined.
The following experiment was conducted to ascertain whether
the above GSH, cysteine, and f3-mercaptoethanol effects on cell
viability/lipid peroxidation were uniquely expressed in post-glyc-
erol tubules, or whether they also could be observed in normal
PTS. To this end, six separate PTS preparations were obtained
from normal rats and they were treated in an identical fashion to
that just described.
GSH effects on iron-induced peroxidation of phosphatidyicholine
The following experiment tested whether GSH's impact on lipid
peroxidation is uniquely expressed in cellular preparations (that
is, does it require cellular GSH "processing" such as release of
cysteine), or can it also be demonstrated in a cell free system? To
this end, phosphatidylcholine (200 jig; with palmitate and arachi-
donate in the sn 1 and sn 2 positions, respectively; from Sigma
Chemicals; P-0319) was incubated in 400 jil of PTS incubation
buffer (no tubules present) at 37°C for 30 minutes under one of
the following test conditions: (1) no additions (control incuba-
tion); (2) 0.5 mrvi FeSO4 addition; (3) FeSO4 + 4 mrvt GSH; (4)
FeSO4 + 4 mM cysteine; (5) FeSO4 + 4 mM glutamic acid; (6)
FeSO4 + 4 mivi glycine; and (7) FeSO4 + 4 mrvt /3-mercaptoetha-
nol. At the completion of the incubations, the reactions were
stopped by addition of 100 j.rl of 25 mM DFO + 25 mrvi EDTA and
the samples were immediately assayed for MDA (jimol/liter).
To confirm that GSFI and cysteine-induced lipid peroxidation in
the above experiments (Results) was iron dependent, two addi-
tional sets of experiments were performed: first, GSH, cysteine,
and 13-mercaptoethanol were incubated with phosphatidylcholine
in the absence of FeSO4, and increments in MDA were sought
(N = 3 determinations); second, the above-described phosphati-
dylcholine + Fe504 + sulfhydryl compound incubations (GSH,
cysteine, or /3-mercaptoethanol) were repeated (N = 3) in the
presence of DFO to demonstrate that iron chelation prevented
the MDA increments.
Calculations and statistics
All values are presented as means 1 SEM. Comparisons
between post-glycerol and normal (control) tubules were made by
unpaired Student's t-test. Comparisons between aliquots obtained
from post-glycerol PTS were made by paired Student's t-test. The
phosphatidylcholine data were compared by unpaired t-test. The
Bonferroni correction was applied whenever multiple compari-
sons were performed. Statistical significance was judged by a P of
<0.05.
Results
In vitro evolution of glycerol-induced tubular injury
At the time of kidney resection four hours post-glycerol injec-
tion, the kidneys were darkly stained, reflective of myo/hemoglo-
bin trapping within tubular lumina and proximal tubular cell
uptake. At the completion of the isolation process, mild heme
staining of the PTS persisted (consistent with endocytic heme
uptake). Following re-suspension of the PTS preparations in the
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incubation buffer, the baseline % LDH release was —5% for the
post glycerol and normal PTS (Fig. 1A). As previously noted,
comparable total cell yield was obtained from the normal and
post-glycerol kidneys, as assessed by total LDH recovery (316
20 vs. 320 16 U/mI final suspension, respectively).
After just 15 minutes of incubation, the post-glycerol PTS had
doubled their LDH release; in contrast, no increment was noted
in the normal PTS (Fig. 1A). The glycerol exposed tubules
manifested ongoing injury over the course of the experiments (47
2% LDH release after 90 mm incubations). In contrast, the %
LDH from the normal tubules increased to just 11 1% by this
time.
A correlate of the evolving injury in the post-glycerol PTS was
a progressive rise in MDA concentrations (Fig. 1B). In contrast,
the normal PTS manifested no MDA increments over the course
of the experiments. Thus, by the end of the experiments, there was
a 20-fold difference in MDA levels for the two sets of tubules.
Effect of iron chelation therapy on the expression of post-glycerol
PTS injury
In these experiments, the post-glycerol PTS developed 36 3%
LDH release over the 90 minute incubations (Fig. 2A). Addition
of DFO at the start of these incubations conferred modest
protection, decreasing % LDH release from 36% to 22% (P <
0.01; Fig. 2A). However, DFO addition during collagenase diges-
tion was completely cytoprotective, since only 13 1% LDH
release developed (NS vs. 11 1% LDH release for normal
tubules after 90 mm incubations, as per Fig. 1A). The presence of
DFO both during collagenase digestion and the 90-minute exper-
imental incubations yielded comparable results to that just noted
(as expected, since the presence of DFO just during collagenase
digestion was completely cytoprotective). DFO addition to the
collagenase digestion buffer did not affect tubule recovery, as
assessed by total LDH recovery (264 30 vs. 252 16 U/mI;
DFO).
Addition of DFO at the start of the 90 minute incubations
almost completely abrogated glycerol-triggered lipid peroxida-
tion, reducing the MDA levels from 1.2 to 0.2 nmol/mg protein
(P < 0.05; Fig. 2B). DFO addition during the collagenase
digestion process was even more protective since the resulting
Fig. 2. Impact of DFO on LDH release (A) and
MDA generation (B) in PTS ha,vested from
glycerol injected rats. Numbers represent: 1 = no
DFO addition; 2 = DFO addition during the
90 minute incubations only; 3 = DFO addition
during collagenase digestion only; and 4 =
DFO addition during both collagenase digestion
and the 90 minute incuhations. DFO
significantly lessened LDH release/MDA
generation during the incubations (#2), and it
was completely protective when present during
collagenase digestion (#3 or #4; that is,
reducing values to, or below, those observed in
normal PTS; see Fig. 1).
MDA concentrations (0.1 0.05 nmol/mg protein) were identical
to those observed in normal PTS at the end of the 90 minute
incubations (Fig. 1B). The presence of DFO both during the
collagenase digestion + the 90 minute incubation periods reduced
MDA levels to values lower than observed in normal PTS (0.02
0.02 vs. 0.1 0.05, respectively).
•OH generation by normal and post-glycerol PTS
Virtually no DHBA was present in the PTS buffer prior to PTS
addition (zero mm values; Fig. 3A). Over the ensuing 30 minute
incubations, both the normal and the post- glycerol PTS gener-
ated detectable levels of DHBA (Fig. 3A). However, despite
ongoing tubular injury in the post-glycerol tubules (21 4% LDH
release vs. 9 1% for the controls at 30 mm; P < 0.025), the
post-glycerol PTS generated —-30% less DHBA (P < 0.04). DFO
modestly increased DHBA generation by both sets of PTS (Fig.
3B), seemingly dissociating DFO's cytoprotective effect from
decreased 'OH production.
Impact of HO inhibition on post-glycerol PTS injury
Figure 4 depicts the results of experiments conducted on PTS
harvested from rats subjected to glycerol injection concomitant
HO inhibition (Sn protoporphyrin). At each of the three time
points evaluated (30, 60, 90 mm), combined in vivo + in vitro HO
inhibition prevented half of the glycerol-initiated LDH release
(P < 0.001; Fig. 4A). Furthermore, HO inhibition blocked —-75%
of the post-glycerol MDA increments, substantiating that de-
creased oxidant stress had resulted.
When Sn protoporphyrin was added just during collagenase
digestion (that is, not in vivo, as done in the above experiments),
it still attenuated the glycerol-induced PTS injury at every time
point examined, but to a lesser degree than just noted (data not
depicted). For example, after 90 minutes of incubation, % LDH
release without and with Sn protoporphyrin treatment were 44
3% versus 35 3%, respectively (P < 0.03), and the MDA levels
were decreased from 1.3 0.2 to 1.0 0.2 nmol/mg protein,
respectively (P = 0.05 by unpaired t-test; P < 0.0125 by rank sign
test). As previously noted, Sn protoporphyrin decreased neither
LDH release nor lipid peroxidation from normal PTS. Also, it did
not alter total cell recovery, as assessed by total LDH.
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Impact of 'OH scavenger therapy on post-glycerol PTS injuty
Neither DMTU nor benzoate attenuated LDH release or lipid
peroxidation in the post-glycerol PTS after 75 minute incubations
(LDH release: no treatment, 28 2%; benzoate, 32 1%;
DMTU, 28 3%; MDA concentrations: no treatment, 0.9 0.2;
benzoate, 1.1 0.1; DMTU, 0.9 0.16 nmol/mg protein). After
completing 90 minute incubations, there was still no difference in
LDH release (Fig. 5). However, a slight lowering of the MDA
levels were observed with the 'OH scavenger therapy (reaching
statistical significance only with DMTU).
Since DFO may enhance iron dependent .OH generation 15},
the potential for .OH scavenger therapy to improve upon DFO's
cytoprotective effect was sought. However, the extent of DFO-
induced cytoprotection was the same, whether or not DMTU was
present (DFO, 32 2%; DFO + DMTU, 35 1%; Fig. 5A).
Fig. 3. Salicylate trap assessment of .OH
generation over time by normal and post-glycerol
PTS (A). Symbols are: (. .) normal;
(. e) glycerol. Significantly less
hydroxylated by-product (dihydroxybenzoic acid,
or DHBA) was generated by the post-glycerol
group (P < 0.04). DFO enhanced DHBA
generation in both the normal and post-glycerol
PTS (B) despite its cytoprotective effect (21
4% vs. 9 1% LDH release for the post-
glycerol PTS without and with DFO addition
after these 30 mm incubations; P < 0.025).
Symbols are: (LI) normal; () glycerol.
Similarly, DMTU did not alter the extent to which DFO de-
creased MDA generation (DFO, 0.4 0.05; DFO+DMTU, 0.4
0.03; Fig. 5B).
Impact of GSH and catalase on post-glycerol PTS injuty
As shown in Figure 6A, GSH exerted a slight, but statistically
significant, cytoprotective effect. A correlate of this GSH-medi-
ated protection was a paradoxical increase in MDA generation
(Fig. 6B). Neither glycine nor catalase had a significant impact on
LDH release or on MDA levels.
Assessments of GSH's "pro-oxidant" effect
As shown in Figure 7A, GSH induced a fourfold rise in MDA
levels in normal PTS (from 0.15 to 0.60 nmol/mg protein; P <
0.002), indicating that its pro-oxidant effect was not confined to
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Fig. 4. Impact of Sn protopoiphyrin treatment
(in vivo, + during collagenase digestion) on the
evolution of glycerol-triggered LDH release (A)
and lipid peroxidation (B). At each of the time
points evaluated (30, 60, 90 mm of incubation),
the PTS exposed to Sn protoporphyrmn had
significantly less injury, as reflected by these
two parameters. Symbols are: () glycerol + Sn
protoporphyrin; () glycerol.
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Fig. 5. Effects of Na benzoate (benz) and
dimethylthiourea (DMTU) on LDH release (A)
and lipid peroxidation (B) by post-glycerol PTS
over the course of 90 minutes incubations. C is
control incubations (no additions). Neither
agent decreased LDH release. DMTU and
benzoate slightly reduced lipid peroxidation, but
only the DMTU result achieved statistical
significance. Combination DFO + DMTU was
no more protective than DFO alone, further
suggesting that .OH was not the mediator of
cell death.
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the post-glycerol PTS. That DFO completely blocked the GSH-
induced MDA increments in both the normal and post-glycerol
PTS preparations (Fig. 7 A, B) indicated the iron dependent
nature of this reaction. Cysteine completely reproduced GSH's
"pro-oxidant" effect (Fig. 7 A, B), suggesting that it was respon-
sible. p-mercaptoethanol slightly raised MDA levels in the normal
PTS (from 0.2 to 0.3 nmol/mg protein; P < 0.01). However, unlike
GSH and cysteine, 13-mercaptoethanol reduced lipid peroxidation
in the post-glycerol PTS to essentially normal levels.
None of the above reagents had any impact on LDH release
from the normal PTS (Fig. 7C). When added to the post-glycerol
PTS, GSH only slightly lowered % LDH release (NS is this
particular comparison, but P < 0.001 when combined with the
data shown in Fig. 6). Cysteine conferred no cytoprotective effect
(Fig. 7C). /3-mercaptoethanol was only slightly cytoprotective(lowering LDH release from 47 0% to 35 1%; P < 0.001),
despite the fact that it eliminated the post-glycerol increments in
MDA production.
Assessments of GSI-I effects on lipid peroxidation in a cell
free system
In the absence of FeSO4 addition, minimal MDA generation
occurred during the phosphatidyicholine incubations (Fig. 8).
FeSO4 caused an approximate sixfold MDA increment, and its
extent was dramatically increased by GSH. That both cysteine and
P<0.01
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Fig. 6. Effects of GSH, glycine (gly), and
catalase (cat) on post-glycerol LDH release (A)
and MDA generation (B) over the course of 90
minute incubations. C is control incubations
(that is, no additions). GSH induced a slight,
but significant, decrease in LDH release.
Glycine conferred no protection, indicating that
this GSH effect was not due to its glycine
content. A correlate of the GSH-induced
protection was a striking increase in MDA
production. Catalase had no demonstrable
effects.
0 mm C GSH Gly Cat
90 minutes
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Fig. 8. MDA generation (jiinollliter) during phosphatidyicholine incuba-
(ions either in the absence of FeSO4 (no Fe2), in the presence of FeSO4
alone ("0"), or in the presence of FeSO4 + a test reactant [GSI-I, glycine
(gly), glutamic acid (glut), cysteine (cyst) or 13-mercaproethanol (13M)j. Each
of the sulfhydryl containing compounds increased FeSO4-induced peroxi-
dation, whereas neither glycine nor glutamic acid did so (P values in
comparison to the FeSO4Ino addition group). In data not depicted,
neither cysteine, GSH, nor 13-mercaptoethanol caused MDA generation in
the absence of FeSO4. Also not shown, DFO blocked lipid peroxidation in
all of these incubations (indicating its iron dependence).
J3-mercaptoethanol, but neither glycine nor glutamic acid, repro-
duced GSH's "pro-oxidant" effect suggested that the sulfhydryl
component of GSH was responsible. In data not depicted, GSH,
cysteine, and -mercaptoethanol each failed to increase MDA
generation in the absence of FeSO4 (that is, they exerted no
independent oxidant effect). Furthermore, none of these corn-
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Fig. 7. Impacts of GSH DFO, cysteine (cyst),
and /3-mercaptoethanol (/3M) on MDA
generation by (A) normal and (B) post-glycerol
P1'S. C means control incubations (no
additions). GSH induced lipid peroxidation in
both normal and post-glycerol PTS, a result
which was blocked by DFO. That cysteine
reproduced these results suggests that it was
responsible for the GSH effect. f3-
mercaptoethanol induced slight lipid
peroxidation in the normal tubules, while
blocking it in the post-glycerol PTS. (P values
in comparison to the control incubation values).
(C) None of the test agents affected LDH
release from the normal PTS. (D) Despite
inducing a marked increase in MDA, cysteine
did not alter LDH release in the post-glycerol
PTS. 13-mercaptoethanol only partially
protected the post-glycerol PTS, as assessed by
LDH release, despite eliminating lipid
peroxidation. GSH induced only trivial
cytoprotection (NS in this particular
comparison, but P < 0.001 when combined with
the Fig. 6 data).
pounds increased FeSO4-mediated lipid peroxidation in the pres-
ence of DFO.
Discussion
The first goal of this study was to establish a method which
would permit direct assessments of myohemoglobinuric tubular
injury in the absence of confounding intraluminal and hemody-
namic events. Theoretically, direct addition of heme proteins to
normal PTS should accomplish this objective. However, prior
experience indicates that in vitro heme protein exposure induces
no overt PTS damage [30]. Thus, it was reasoned that myohemo-
globinuria would need to be induced in vivo (permitting heme
endocytosis/intracellular catabolism/cast formation/renal vasocon-
striction), prior to PTS isolation. In a previous study, attempts to
achieve a workable model of in vitro heme protein-induced injury
was made by high dose myoglobin infusion [31]. Although proxi-
mal tubular heme loading was produced, virtually no in vitro
tubular damage resulted [31]. One possible explanation for this is
that myoglobin infusion causes intravascular volume expansion,
mitigating its toxic effects [15, 20]. Furthermore, heme protein
infusion is not associated with tissue disruption (myolysis/hemo-
lysis), which may impact on the evolution of tubular damage (such
as [11, 12]). Thus, in this study, rats were subjected to glycerol
injection, inducing hemolysis/myolysis, and four hours later PTS
were harvested for investigation. As depicted in Figure 1, this
protocol achieved the desired objective, since a marked, progres-
sive rise in LDH release occurred during subsequent in vitro
incubations. In contrast, minimal LDH release occurred from
normal tubules.
It should be noted that at four hours post-glycerol injection, cell
injury (brush border blebbing), but not necrosis, is typically
observed in whole kidney morphologic sections (unpublished
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observations; R. Zager). However, when tubules are extracted
from these kidneys and incubated in vitro, cell death rapidly
develops (Fig. 1). This apparent descrepancy in timing of cell
death raises the possibility that the tubule extraction process
accentuates the rate of the evolving heme-induced damage.
Alternatively, it could be that a comparable rate of lethal injury
occurs in vivo and in vitro, but the relative insensitivity of
morphology as an early marker of in vivo injury precludes accurate
timing assessments. Whatever the exact explanation, it remains
clear that the described model does permit establishment of a
clinically relevant heme-induced insult in vivo which can then be
directly studied in the in vitro setting. To our knowledge, this is the
only model of this kind.
A striking correlate of the evolving injury in the post-glycerol
exposed tubules was a progressive rise in MDA concentrations.
That no increase was noted in the normal tubules indicates that
this process was reflective of glycerol-triggered lipid peroxidation,
rather than tubular incubation, per se. From this laboratory's
perspective, the issue of lipid peroxidation during myohemoglo-
binuric renal damage has been in doubt [19, 201 because intrare-
nal heme pigment trapping imposes a prominent colorimetric
artifact on tissue MDA assays [20]. However, PTS isolation
removes most of the heme trapped within the tubular system,
thereby allowing for more accurate MDA assessments. Therefore,
that marked MDA increments occurred during the course of the
present experiments seemingly proves that lipid peroxidation is, in
fact, a striking feature of evolving heme-induced proximal tubular
damage. In a recent study from this laboratory, PTS were har-
vested from rats 24 hours following glycerol injection and no
MDA increments were noted [18]. That we now document
massive lipid peroxidation at four hours post-glycerol injection
indicates the transient nature of the peroxidative process; thus,
assay timing is critical.
A second issue which the current study resolves is the relative
importance of free iron in the induction of heme-mediated
proximal tubular injury. As shown in Figure 2A, DFO addition at
the start of the experimental incubations conferred substantial
protection, approximately halving glycerol-triggered LDH release.
However, when added during collagenase digestion, cell death
and lipid peroxidation during the subsequent 90 minute incuba-
lions was completely prevented (that is, equal values for the
post-glycerol vs. normal tubules). Thus, these experiments dem-
onstrate that chelatable iron is the prime determinant of direct
heme-induced proximal tubular injury. These results stand in
contrast to previous in vivo glycerol ARF experiments in which
DFO has conferred a rather modest protective effect [13—16].
Undoubtedly, this quantitative discrepancy reflects the fact that
multiple determinants of in vivo renal function exist (such as
vasoconstriction, cast formation), in addition to direct tubular
injury. Furthermore, in vitro experiments guarantee delivery of
therapeutic levels of protective agents during the most critical
period. That DFO was more protective when added during PTS
isolation versus the subsequent experimental incubations under-
scores the importance of this latter issue.
That DFO chelates free, but not porphyrin bound iron, and that
DFO completely blocked post-glycerol tubule injury suggest that
heme iron must be liberated from the porphyrin ring to induce
toxicity. If so, then prior observations [17, 18] that HO inhibition
at the time of glycerol injection exacerbates the maintenance
phase of the resulting ARF seems paradoxical. This is because
HO inhibition blocks porphyrin iron release, theoretically de-
creasing the free iron burden [21]. Thus, one would expect that
acute HO inhibition would be cytoprotective. To test this hypoth-
esis, the impact of HO inhibition on glycerol-triggered tubular
injury was tested in our new model. As shown in Figure 4,
combined in vivo + in vitro Sn protoporphyrin treatment markedly
attenuated glycerol-induced lipid peroxidation and cell death. To
substantiate this conclusion, additional experiments were con-
ducted in which Sn protoporphyrin was added only in vitro,
thereby eliminating potentially confounding nontubular in vivo
effects. Once again, cytoprotection was induced. That Sn proto-
porphyrin had no impact on lipid peroxidation or LDH release
from normal tubules confirmed the specificity of these findings for
the heme-loaded PTS. Thus, it appears that HO is an acute
mediator of heme protein nephrotoxicity, rather than a classic
cytoprotectant, as previously suggested by in vivo experiments [17,
18]. However, the current and previous results [17, 18] are not
necessarily contradictory. For example, if one increases or de-
creases HO expression over a 24 hour period [17, 18], many
indirect "downstream" consequences can result which would not
occur with acute manipulations. For example, only with a signif-
icant lag time would increased ferritin production result. Further-
more, maneuvers which increase HO over a 24 hour period may
have many additional and unrelated influences. For example, we
have recently reported [18] that after a 24 hour delay, heme
exposed tubules develop a broad based cytoprotective state
operative against hypoxia, phospholipase, cytochalasin D, Ca2
ionophore, FeSO4 [18], and the current heme toxicity model
(unpublished observations). The data also indicated that this
cytoresistance was due to a primary increase in plasma membrane
resistance to attack, and that this could be dissociated from
increased HO/ferritin expression [18]. Thus, the available data
indicate that: (1) acute and delayed effects of HO expression!
inhibition are not necessarily the same; and (2) increased HO
expression can correlate with cytoresistance and not necessarily be
the cause of it.
It has traditionally been assumed that iron-induced oxidant
stress is mediated via generation of .OH radical from H2O2 via
the Fenton!Haber Weiss reactions [32, 33]. However, Wink et al
have recently suggested that the "Fenton reagent is simply an
inadequate model for in vivo metal-catalyzed oxidations by per-
oxide . . . or.. . the importance of .OH has been broadly overes-
timated" [34]. To pursue this issue with our new in vitro model of
iron-induced tubular injury, two approaches were taken: first,
•OH production was determined by the salicylate trap method;
and second, the ability of .OH scavengers and catalase to mitigate
injury was assessed. The results of those studies support Wink's
view: (1) DHBA!.OH generation was depressed, rather than
increased, in the glycerol-exposed PTS (possibly because heme
proteins can act as an •OH scavenger [30]; (2) DFO increased,
rather than decreased, DHBA production (possibly by accelerat-
ing Fe2 autoxidation [15]; and (3) neither •OH scavenger nor
catalase therapy mitigated the extent of post-glycerol tubular cell
death. Thus, .OH does not appear to be the mediator of heme
iron-induced tubular injury in the employed model system, sug-
gesting that the recently recognized non-'OH oxidizing interme-
diates described by Wink et al (which they denoted "x" and "y")
could be involved [34].
Abul-Ezz, Walker and Shah have reported that GSH can
provide partial protection against the glycerol model of ARF [16].
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However, Scaduto et a! have noted that GSH (given as a methyl
ester to enhance cell uptake) can exacerbate post-ischemic ARF,
indicating potential toxic effect(s) [22]. Therefore, to elucidate
GSH's direct impact on myohemoglobinuric tubular injury, it was
added directly to the post-glycerol PTS. Very weak cytoprotection
was noted, as assessed by LDH release. That equimolar glycine
did not reproduce this result indicates that glycine (potentially
released by GSH breakdown) was not responsible [29]. However,
GSH's most dramatic impact on post-glycerol injury was that it
markedly potentiated lipid peroxidation, with MDA levels rising
from 1.8 to 4.9 nmol/mg protein. Thus, as suggested by the above
in vivo data, GSH can, indeed, exert beneficial [16], as well as
adverse [22] effects on proximal tubular epithelium.
To explore the molecular basis for GSH's pro-oxidant effect,
the impact of each of its three constituent amino acids on lipid
peroxidation was assessed using normal PTS, post-glycerol PTS,
and phosphatidyicholine as targets. Those experiments clearly
identified cysteine as the responsible component, since it, but
neither glycine nor glutamic acid, reproduced GSH's pro-oxidant
effect. It has previously been reported that cysteine can induce
oxidant stress in the presence of transition metals via its oxidation,
H202 production being a result [35, 36]. Hence, this raises the
possibility that GSH's pro-oxidant effect was merely due to tubule
GSH metabolism with cysteine release. However, that GSH
caused iron dependent lipid peroxidation in a cell free system
(phosphatidyicholine experiments) clearly rules out this possibil-
ity. To determine whether any sulthydryl-containing compound
would enhance lipid peroxidation, the impact of 3-mercaptoetha-
nol was also assessed. It induced lipid peroxidation of both normal
PTS and of phosphatidyicholine; however, it almost completely
blocked the spontaneous lipid peroxidation of the post-glycerol
PTS. The reason for the differing responses in the normal and
post-glycerol tubules remains unknown. Nevertheless, these diver-
gent findings are important since they graphically illustrate that a
given "antioxidant" may exert either a pro-oxidant or an anti-
oxidant effect, depending on the target encountered (in this case,
normal or heme loaded PTS). This underscores the difficulty in
predicting the impact of a given antioxidant when introduced into
complex biologic reactions.
A question which arises from the current study is whether lipid
peroxidation is a critical pathway leading to heme iron-induced
cell death. That DFO and HO inhibition each conferred protec-
tion while lowering MDA suggests that the answer is yes. How-
ever, the extent of cell injury and lipid peroxidation were clearly
dissociated in the GSH and cysteine addition experiments. The
reason for this remains unknown. It could be that critical lipid
peroxidation is quite site specific, and hence, total MDA mea-
surements mask the most important changes. Alternatively, oxi-
dation of proteins or other non-lipid targets, such as DNA, may be
more important. Since the critical targets for heme-induced
toxicity remain unknown, only speculation regarding this issue is
possible at this time.
In conclusion, the present study describes a novel model for
studying myohemoglobinuric proximal tubular injury: it permits
induction of injury in vivo (assuring a clinically relevant insult) and
then permits assessments directly at the proximal tubular cell
level. Using this model, the following insights have been obtained:
(1) Free (chelatable) iron is the primary and dominant factor
which mediates myolysis/hemolysis-induced proximal tubular in-
jury (since DFO confers complete protection). (2) Heme oxyge-
nase is a critical determinant of that injury, presumably by acutely
causing heme iron release. Hence, the view of heme oxygenase as
a cytoprotectant needs to be interpreted in this new context. (3)
Myohemoglobinuric renal injury induces striking lipid peroxida-
tion directly at the proximal tubular level. Nevertheless, this
process and heme-triggered lethal cell injury may not be directly
linked. (4) That neither •OH scavengers nor catalase protect
against this model of myohemoglobinuric injury, and that no
increased •OH generation (salicylate oxidation) results, suggest
that recently recognized non-.OH, iron-catalyzed, oxidizing inter-
mediates are more likely to be involved [34]; and (5) glutathione,
while slightly cytoprotective, can also exert a marked pro-oxidant
effect. This latter reaction is iron (transition metal) dependent, it
can be expressed in a cell- or cell-free system, and it appears to be
determined by GSH's cysteine content. Thus, GSH's impact on
complex biologic systems cannot be readily predicted, since either
beneficial or potentially adverse effects may result.
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